← Leaderboards
Josep Maria Mercader
Broad Institute, Inc.
$3,034,574
Attributed
$8,662,631
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,662,631 · 4
By mechanism
U01$6,420,862 · 2
R01$2,241,769 · 2
Top collaborators
- Alisa Knodle Manning5 shared
- Maggie Ng5 shared
- Miriam Sargon Udler5 shared
- Arjun Kumar Manrai2 shared
- Chirag J. Patel2 shared
- Kristina Marie Utzschneider2 shared
Most similar at Broad Institute, Inc.
Same institution · by research overlap
- Ramnik J Xavier$68,708,013
- Benjamin Michael Neale$29,893,108
- Jason Daniel Buenrostro$12,771,879
- So Mi Cho$165,364
Others in their field
Other Emerging Leaders on “Population Heterogeneity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Kathleen Maletic Neuzil · Emory University$26,789,412
- George Robert Painter · University Of Alabama At Birmingham$25,957,440
- Jennifer Marie Suga · Kaiser Foundation Research Institute$21,704,579
Research focus
Population HeterogeneityDiabetes MellitusCohortGeneticGenomicsPhenotypeTraitPatient CarePersonalized CarePolygenic Risk ScoreGenome Wide Association StudyClinical RiskDiabetes RiskPrecision MedicineComplexGlobal HealthVariantBiobankNon-Insulin-Dependent Diabetes MellitusRisk FactorsPersonsGenomic DataGenetic Risk FactorGenetic Variant
Grant awards (12)
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Multiple Ancestries$949,464
U01 · FY2025 · HG · contact PI
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$785,491
R01 · FY2025 · DK · contact PI
GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes in Diverse Populations (GEMS-T2D)$784,318
U01 · FY2025 · DK
Cataloging multi-ancestry 'omic readouts of the environmental and genetic determinants of type 2 diabetes$670,412
R01 · FY2025 · DK
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$64,289
R01 · FY2025 · DK · contact PI
Massive-scale genomic risk assessment to inform precision medicine across the spectrum of monogenic and common forms of diabetes$32,400
R01 · FY2025 · DK · contact PI
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Diverse Ancestry$963,817
U01 · FY2024 · HG · contact PI
GEneration and assessment of Multi-omic informed Subtypes of Type 2 Diabetes in Diverse Populations (GEMS-T2D)$784,636
U01 · FY2024 · DK
Cataloging multi-ancestry 'omic readouts of the environmental and genetic determinants of type 2 diabetes$689,177
R01 · FY2024 · DK
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Diverse Ancestry$966,817
U01 · FY2023 · HG · contact PI
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Diverse Ancestry$984,927
U01 · FY2022 · HG · contact PI
Development of Polygenic Risk Scores for Diabetes and Complications across the Life-Span in Populations of Diverse Ancestry$986,883
U01 · FY2021 · HG · contact PI